Ensign Peak Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$103K	Hold	8,069	–	–	﹤0.01%	1559
2025 Q4	$72.5K	Sell	8,069 -13,350	-62%	-$184K	﹤0.01%	1631
2025 Q3	$370K	Sell	21,419 -17,750	-45%	-$219K	﹤0.01%	1513
2025 Q2	$367K	Hold	39,169	–	–	﹤0.01%	1627
2025 Q1	$278K	Hold	39,169	–	–	﹤0.01%	1650
2024 Q4	$457K	Buy	39,169 +1,100	+3%	+$17.2K	﹤0.01%	1625
2024 Q3	$782K	Buy	38,069 +2,050	+6%	+$47.3K	﹤0.01%	1453
2024 Q2	$806K	Buy	36,019 +6,850	+23%	+$163K	﹤0.01%	1418
2024 Q1	$802K	Sell	29,169 -1,471	-5%	-$40.9K	﹤0.01%	1462
2023 Q4	$934K	Hold	30,640	–	–	﹤0.01%	1425
2023 Q3	$969K	Hold	30,640	–	–	﹤0.01%	1228
2023 Q2	$1.25M	Hold	30,640	–	–	﹤0.01%	1086
2023 Q1	$1.14M	Hold	30,640	–	–	﹤0.01%	1138
2022 Q4	$1.07M	Buy	30,640 +13,900	+83%	+$661K	﹤0.01%	1107
2022 Q3	$937K	Sell	16,740 -77,677	-82%	-$4.82M	﹤0.01%	1104
2022 Q2	$4.89M	Buy	94,417 +78,277	+485%	+$3.97M	0.01%	547
2022 Q1	$1.17M	Hold	16,140	–	–	﹤0.01%	1109
2021 Q4	$1.91M	Buy	+16,140	New	+$2.02M	﹤0.01%	978